Said Darwazah, the Chief Executive Officer of Hikma Pharmaceuticals, the FTSE 250 multinational pharmaceutical group, has pocketed over one million pounds through the sale of company shares last week.
Darwazah sold 195,447 shares at 649p each on June 15th for a total of £1,268,451, the company revealed in a statement on Thursday. This was equal to 0.99% of the issued share capital of Hikma.
Following the transaction, he still owns over two million shares in the firm, equal to a 1.08% stake.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Darwazah is the former Minister of Health in Jordan from 2003 to 2006 and also held a position on the board of the Central Bank of Jordan.
Last month, the company reiterated its revenue growth guidance for 2012. "We are making good progress towards delivering our targets for this year and surpassing the important milestone of $1bn in revenue," Darwazah said at the time.
The group announced 28% growth in its branded business during the first four months of the year, along with 12% organic revenue growth.
Top Director Buys
New Europe Property Investments (NEPI)
Director name: Mr Corneliu-Dan Pascariu
Amount purchased: 131,500 @ €3.50
Value: €460,250
Ruspetro (RPO)
Director name: Mr Christopher Clark
Amount purchased: 100,000 @ 134.00p
Value: £134,000
Jupiter Energy Ltd (JPRL)
Director name: Mr Alastair Beardsall
Amount purchased: 333,333 @ 28.15p
Value: £93,833
KBC Advanced Technologies (KBC)
Director name: Mr Ian Godden
Amount purchased: 80,000 @ 73.25p
Value: £58,600
KBC Advanced Technologies (KBC)
Director name: Mr Michael Peter Kirk
Amount purchased: 70,000 @ 73.25p
Value: £51,275
Helius Energy (HEGY)
Director name: Mr Angus MacDonald OBE
Amount purchased: 250,000 @ 16.50p
Value: £41,250
Helius Energy (HEGY)
Director name: Mr Angus MacDonald OBE
Amount purchased: 250,000 @ 16.50p
Value: £41,250
Norcros (NXR)
Director name: Mr Martin Payne
Amount purchased: 300,000 @ 11.96p
Value: £35,880
TR European Growth Trust (TRG)
Director name: Mr Christopher Casey
Amount purchased: 6,000 @ 287.12p
Value: £17,227
Ncondezi Coal Co Ltd. (DI) (NCCL)
Director name: Mr Graham Edward Mascall
Amount purchased: 50,000 @ 30.50p
Value: £15,250
Top Director Sells
Hornby (HRN)
Director name: Mr Frank Martin
Amount sold: 13,871 @ 78,500.00p
Value: £10,888,735
Hikma Pharmaceuticals (HIK)
Director name: Mr Said Darwazah
Amount sold: 195,447 @ 649.00p
Value: £1,268,451
Hammerson (HMSO)
Director name: Mr Timon Drakesmith
Amount sold: 134,679 @ 431.26p
Value: £580,817
Tate & Lyle (TATE)
Director name: Mr Robert Gibber
Amount sold: 66,627 @ 634.41p
Value: £422,688
RIT Capital Partners (RCP)
Director name: Mr Mikael Breuer-Weil
Amount sold: 30,450 @ 1,230.73p
Value: £374,757
KBC Advanced Technologies (KBC)
Director name: Mr Nicholas Stone
Amount sold: 349,609 @ 73.25p
Value: £256,089
New Europe Property Investments (NEPI)
Director name: Mr Victor Semionov
Amount sold: 50,000 @ €3.50
Value: €175,000
Invensys (ISYS)
Director name: Ms Victoria Hull
Amount sold: 15,330 @ 201.06p
Value: £30,822
S & U (SUS)
Director name: Mr Guy Thompson
Amount sold: 2,000 @ 835.00p
Value: £16,700
BC
-
How to invest in US small capsFor more than a decade, US small caps have lagged their larger counterparts. There are signs this is starting to change – here's how to stock up
-
Two investment trusts riding the AI boomRemain invested in investment trusts despite high valuations, as computing breakthroughs are likely to change the world
